Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS vs SHAMROCK IND - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AARTI DRUGS SHAMROCK IND AARTI DRUGS/
SHAMROCK IND
 
P/E (TTM) x 27.3 -42.8 - View Chart
P/BV x 3.2 3.7 88.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 AARTI DRUGS   SHAMROCK IND
EQUITY SHARE DATA
    AARTI DRUGS
Mar-24
SHAMROCK IND
Mar-24
AARTI DRUGS/
SHAMROCK IND
5-Yr Chart
Click to enlarge
High Rs64511 5,774.4%   
Low Rs3363 10,634.5%   
Sales per share (Unadj.) Rs275.00-  
Earnings per share (Unadj.) Rs18.7-0.1 -24,717.6%  
Cash flow per share (Unadj.) Rs24.3-0.1 -32,128.5%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs139.43.2 4,375.1%  
Shares outstanding (eoy) m91.945.43 1,693.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.80-  
Avg P/E ratio x26.3-96.0 -27.4%  
P/CF ratio (eoy) x20.2-96.0 -21.1%  
Price / Book Value ratio x3.52.2 156.5%  
Dividend payout %5.40-   
Avg Mkt Cap Rs m45,09639 115,944.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9060 503,316.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m25,2860-  
Other income Rs m401 3,598.2%   
Total revenues Rs m25,3261 2,261,256.3%   
Gross profit Rs m3,208-2 -211,074.3%  
Depreciation Rs m5140-   
Interest Rs m3790-   
Profit before tax Rs m2,3550 -574,458.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6390-   
Profit after tax Rs m1,7160 -418,514.6%  
Gross profit margin %12.70- 
Effective tax rate %27.10-   
Net profit margin %6.80- 
BALANCE SHEET DATA
Current assets Rs m13,20716 80,433.6%   
Current liabilities Rs m7,9550 2,651,810.0%   
Net working cap to sales %20.80- 
Current ratio x1.754.7 3.0%  
Inventory Days Days60- 
Debtors Days Days1,0170- 
Net fixed assets Rs m11,1161 942,066.1%   
Share capital Rs m91954 1,693.7%   
"Free" reserves Rs m11,896-37 -32,169.1%   
Net worth Rs m12,81517 74,078.0%   
Long term debt Rs m2,7530-   
Total assets Rs m24,32418 138,202.2%  
Interest coverage x7.20-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.00-   
Return on assets %8.6-2.3 -373.3%  
Return on equity %13.4-2.3 -570.5%  
Return on capital %17.6-2.3 -748.3%  
Exports to sales %26.60-  
Imports to sales %32.60-  
Exports (fob) Rs m6,728NA-   
Imports (cif) Rs m8,239NA-   
Fx inflow Rs m6,7280-   
Fx outflow Rs m8,3860-   
Net fx Rs m-1,6570-   
CASH FLOW
From Operations Rs m3,5890 -970,062.2%  
From Investments Rs m-2,237NA-  
From Financial Activity Rs m-1,360NA-  
Net Cashflow Rs m-80 2,056.8%  

Share Holding

Indian Promoters % 55.6 43.0 129.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 10.3 0.0 -  
FIIs % 2.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.4 57.0 77.8%  
Shareholders   190,281 2,898 6,565.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AARTI DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AARTI DRUGS vs SHAMROCK IND

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AARTI DRUGS vs SHAMROCK IND Share Price Performance

Period AARTI DRUGS SHAMROCK IND S&P BSE HEALTHCARE
1-Day -0.16% 1.92% 0.84%
1-Month -6.90% 34.87% -0.63%
1-Year -6.01% 125.92% 43.06%
3-Year CAGR -3.42% 29.25% 20.20%
5-Year CAGR 28.48% 16.64% 26.15%

* Compound Annual Growth Rate

Here are more details on the AARTI DRUGS share price and the SHAMROCK IND share price.

Moving on to shareholding structures...

The promoters of AARTI DRUGS hold a 55.6% stake in the company. In case of SHAMROCK IND the stake stands at 43.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AARTI DRUGS and the shareholding pattern of SHAMROCK IND.

Finally, a word on dividends...

In the most recent financial year, AARTI DRUGS paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.4%.

SHAMROCK IND paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of AARTI DRUGS, and the dividend history of SHAMROCK IND.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.